IL122891A0 - Pharmaceutical compositions comprising a thiocarbamate - Google Patents

Pharmaceutical compositions comprising a thiocarbamate

Info

Publication number
IL122891A0
IL122891A0 IL12289198A IL12289198A IL122891A0 IL 122891 A0 IL122891 A0 IL 122891A0 IL 12289198 A IL12289198 A IL 12289198A IL 12289198 A IL12289198 A IL 12289198A IL 122891 A0 IL122891 A0 IL 122891A0
Authority
IL
Israel
Prior art keywords
thiocarbamate
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL12289198A
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL12289198A priority Critical patent/IL122891A0/en
Publication of IL122891A0 publication Critical patent/IL122891A0/en
Priority to EP99900281A priority patent/EP1049441A2/en
Priority to IL13721099A priority patent/IL137210A0/en
Priority to US09/600,001 priority patent/US6740681B1/en
Priority to JP2000527218A priority patent/JP2002500170A/en
Priority to AU18886/99A priority patent/AU1888699A/en
Priority to PCT/IL1999/000018 priority patent/WO1999034763A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL12289198A 1998-01-11 1998-01-11 Pharmaceutical compositions comprising a thiocarbamate IL122891A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL12289198A IL122891A0 (en) 1998-01-11 1998-01-11 Pharmaceutical compositions comprising a thiocarbamate
EP99900281A EP1049441A2 (en) 1998-01-11 1999-01-11 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
IL13721099A IL137210A0 (en) 1998-01-11 1999-01-11 Pharmaceutical compositions comprising thiram
US09/600,001 US6740681B1 (en) 1998-01-11 1999-01-11 Pharmaceutical compositions comprising thiram
JP2000527218A JP2002500170A (en) 1998-01-11 1999-01-11 Pharmaceutical composition comprising thiram
AU18886/99A AU1888699A (en) 1998-01-11 1999-01-11 Pharmaceutical compositions comprising thiram
PCT/IL1999/000018 WO1999034763A2 (en) 1998-01-11 1999-01-11 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12289198A IL122891A0 (en) 1998-01-11 1998-01-11 Pharmaceutical compositions comprising a thiocarbamate

Publications (1)

Publication Number Publication Date
IL122891A0 true IL122891A0 (en) 1998-08-16

Family

ID=11071075

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12289198A IL122891A0 (en) 1998-01-11 1998-01-11 Pharmaceutical compositions comprising a thiocarbamate

Country Status (6)

Country Link
US (1) US6740681B1 (en)
EP (1) EP1049441A2 (en)
JP (1) JP2002500170A (en)
AU (1) AU1888699A (en)
IL (1) IL122891A0 (en)
WO (1) WO1999034763A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548540B2 (en) 1998-09-08 2003-04-15 Charlotte-Mecklenburg Hospital Authority Method of treating cancer using dithiocarbamate derivatives
US7816403B2 (en) 1998-09-08 2010-10-19 University Of Utah Research Foundation Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same
US6706759B1 (en) 1998-09-08 2004-03-16 Charlotte-Mecklenburg Hospital Authority Method of treating cancer using dithiocarbamate derivatives
US6589987B2 (en) 1998-09-08 2003-07-08 Charlotte-Mecklenburg Hospital Authority Method of treating cancer using tetraethyl thiuram disulfide
CN112972446A (en) * 2019-12-16 2021-06-18 中国科学院生物物理研究所 Application of TRMT6/TRMT61A inhibitor in treatment of liver cancer
CN115350169A (en) * 2021-05-17 2022-11-18 复旦大学 Application of thiram in preparation of medicine for treating gastric cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870101A (en) * 1987-03-17 1989-09-26 Merrell Dow Pharmaceuticals Inc. Method of inhibiting interleukin-1 release
EP0284879A3 (en) 1987-03-17 1990-10-17 Merrell Dow Pharmaceuticals Inc. Method of inhibiting interleukin-1 release
US5807884A (en) 1992-10-30 1998-09-15 Emory University Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
US5716981A (en) * 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use

Also Published As

Publication number Publication date
AU1888699A (en) 1999-07-26
WO1999034763A3 (en) 2000-08-24
WO1999034763A2 (en) 1999-07-15
US6740681B1 (en) 2004-05-25
JP2002500170A (en) 2002-01-08
EP1049441A2 (en) 2000-11-08

Similar Documents

Publication Publication Date Title
HU9901606D0 (en) Pharmaceutical compositions
PL331531A1 (en) Pharmaceutical aerosol compositions
GB9827996D0 (en) Pharmaceutical Compositions
HUP0103507A3 (en) Pharmaceutical compositions comprising 2-quinolones
GB9727053D0 (en) Pharmaceutical compositions
PL343627A1 (en) Medicinal compositions
CY2569B1 (en) Pharmaceutical compositions
GB9809213D0 (en) Pharmaceutical compositions
IL137505A (en) Pharmaceutical compositions containing tramadol
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
GB9726735D0 (en) Pharmaceutical compositions
IL122891A0 (en) Pharmaceutical compositions comprising a thiocarbamate
AP2000001878A0 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9806487D0 (en) Pharmaceutical compositions
ZA982117B (en) Pharmaceutical compositions
GB9827441D0 (en) Pharmaceutical compositions
GB9814818D0 (en) Pharmaceutical compositions
GB9818953D0 (en) Pharmaceutical compositions
GB9826821D0 (en) Pharmaceutical compositions
GB9826822D0 (en) Pharmaceutical compositions
GB9827006D0 (en) Pharmaceutical compositions
GB9718270D0 (en) Pharmaceutical compositions
GB9710505D0 (en) Pharmaceutical compositions